We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
201
PUT
Accenture
ACN
$87.9B
$56K 0.04%
53,600
+13,700
+34% +$1.56M
POST icon
202
CALL
Post Holdings
POST
$3.94B
$56K 0.04%
36,825
+20,017
+119% +$1.1M
UPS icon
203
CALL
United Parcel Service
UPS
$100B
$56K 0.04%
20,000
STJ
204
CALL
DELISTED
St Jude Medical
STJ
$55K 0.04%
28,800
WOLF icon
205
Wolfspeed
WOLF
$1.55B
$53K 0.04%
+2,073
New +$53.6K
HOG icon
206
PUT
Harley-Davidson
HOG
$2.8B
$52K 0.04%
+8,400
New +$434K
SYNA icon
207
Synaptics
SYNA
$4.46B
$52K 0.04%
880
-600
-41% -$33K
YELP icon
208
PUT
Yelp
YELP
$1.44B
$52K 0.04%
+21,000
New +$736K
AMBA icon
209
CALL
Ambarella
AMBA
$2.71B
$51K 0.04%
+12,500
New +$783K
CBI
210
CALL
DELISTED
Chicago Bridge & Iron Nv
CBI
$51K 0.04%
+33,100
New +$1.07M
FOLD
211
CALL
DELISTED
Amicus Therapeutics
FOLD
$50K 0.04%
+30,400
New +$205K
TAP icon
212
CALL
Molson Coors Class B
TAP
$7.68B
$50K 0.04%
8,400
+2,800
+50% +$285K
KITE
213
PUT
DELISTED
Kite Pharma, Inc.
KITE
$50K 0.04%
+69,900
New +$3.89M
BMY icon
214
CALL
Bristol-Myers Squibb
BMY
$124B
$49K 0.04%
232,500
+182,500
+365% +$11.7M
VEEV icon
215
CALL
Veeva Systems
VEEV
$31.7B
$49K 0.04%
39,900
+19,900
+100% +$772K
DD icon
216
CALL
DuPont de Nemours
DD
$18.3B
$47K 0.04%
11,846
GIS icon
217
CALL
General Mills
GIS
$20.3B
$47K 0.04%
339,500
+168,600
+99% +$11.7M
NBIS
218
PUT
Nebius Group N.V.
NBIS
$45.1B
$46K 0.04%
35,000
ALNY icon
219
CALL
Alnylam Pharmaceuticals
ALNY
$35.7B
$45K 0.04%
15,000
-20,000
-57% -$1.41M
BLUE
220
PUT
DELISTED
bluebird bio
BLUE
$44K 0.03%
1,598
+772
+93% +$559K
WDC icon
221
CALL
Western Digital
WDC
$164B
$44K 0.03%
4,763
-1,217
-20% -$45.9K
CMG icon
222
CALL
Chipotle Mexican Grill
CMG
$44.2B
$43K 0.03%
+250,000
New +$2.06M
META icon
223
PUT
Meta Platforms (Facebook)
META
$1.64T
$43K 0.03%
+29,900
New +$3.71M
FLNA
224
Filana Therapeutics
FLNA
$51.2M
$43K 0.03%
6,214
+1,177
+23% +$19.5K
BHC icon
225
PUT
Bausch Health
BHC
$1.8B
$42K 0.03%
40,000
-10,700
-21% -$277K

Similar funds

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.